Our Story
Our Story
About LucidBio Intelligence
Competitive Intelligence Built by People Who've Been Inside Pharma
Competitive Intelligence Built by People Who've Been Inside Pharma
Our Story
About LucidBio Intelligence
Competitive Intelligence Built by People Who've Been Inside Pharma
We understand the pressure biotech teams face—because we've lived it. LucidBio Intelligence exists to make strategic competitive intelligence accessible, actionable, and fast.
The Problem We Saw
Early-stage biotech companies face an impossible choice when it comes to competitive intelligence:
Option 1:Enterprise platforms like AlphaSense or Cortellis
Cost: £30K-100K+ annually. Require dedicated CI teams to extract value. Built for big pharma, not lean biotech.
The Problem We Saw
Early-stage biotech companies face an impossible choice when it comes to competitive intelligence:
Option 1:Enterprise platforms like AlphaSense or Cortellis
Cost: £30K-100K+ annually. Require dedicated CI teams to extract value. Built for big pharma, not lean biotech.
Our Background
Our Background
Our Background
LucidBio Intelligence was founded with over 30 years of combined experience across pharmaceutical R&D, regulatory affairs, clinical development, medical affairs, and clinical operations.
LucidBio Intelligence was founded with over 30 years of combined experience across pharmaceutical R&D, regulatory affairs, clinical development, medical affairs, and clinical operations.
Our team has worked across;
Our team has worked across;
Our team has worked across;
Big pharma – navigating large-scale drug development programs -
Biotech– understanding the urgency and resource constraints of early-stage companies.
Academia & government research – conducting pharmacology and clinical research in high-stakes environments .
Department of Defense– delivering scientific intelligence under pressure.
We've been on the inside. We know what biotech teams need—and what doesn't work.
Why we started LucidBio
Why we started LucidBio
Why we started LucidBio
We saw talented clinical and regulatory teams spending precious time manually tracking competitors when they should be focused on their own programs. We saw CEOs struggling to answer investor questions about competitive positioning because enterprise CI tools were out of reach.
We started LucidBio to create agility and efficiency in how biotech teams access competitive intelligence—enabling better collaboration, smarter strategic decisions, and faster paths to patient access.
We saw talented clinical and regulatory teams spending precious time manually tracking competitors when they should be focused on their own programs. We saw CEOs struggling to answer investor questions about competitive positioning because enterprise CI tools were out of reach.
We started LucidBio to create agility and efficiency** in how biotech teams access competitive intelligence—enabling better collaboration, smarter strategic decisions, and faster paths to patient access.
Why Choose Us
Why Choose Us
Because We Deliver Intelligence That Matters
Because We Deliver I
ntelligence That Matters
Why Choose Us
Because We Deliver Intelligence That Matters
Focused on Outcomes, Not Noise .
In an era of data overload, we deliver strategic clarity. Every report is built to support action—driving compliance, access, or investment decisions with precision
Insight Backed by Pattern Recognition
We go beyond tracking trends. Our analysis identifies structural shifts, not headlines—pinpointing what’s real, what’s hype, and what’s next for your business
95% Accuracy in Forecasted Outcomes
Our clients rely on us for clear, evidence-based projections that hold up under internal scrutiny. Strategic decisions deserve more than speculation—they require precision.
30 Years of Sector Expertise
LucidBio Intelligence
Focused on Outcomes, Not Noise .
Insight Backed by Pattern Recognition
95% Accuracy in Forecasted Outcomes
30 Years of Sector Expertise
Focused on Outcomes, Not Noise .
In an era of data overload, we deliver strategic clarity. Every report is built to support action—driving compliance, access, or investment decisions with precision
Insight Backed by Pattern Recognition
We go beyond tracking trends. Our analysis identifies structural shifts, not headlines—pinpointing what’s real, what’s hype, and what’s next for your business
95% Accuracy in Forecasted Outcomes
Our clients rely on us for clear, evidence-based projections that hold up under internal scrutiny. Strategic decisions deserve more than speculation—they require precision.
30 Years of Sector Expertise
LucidBio Intelligence
Trusted by companies around the world
Trusted by companies around the world
Trusted by companies around the world
Core Features
Innovative Solutions for Every Business Challenge
Core Features
Innovative Solutions for Every Business Challenge
Core Features
Innovative Solutions for Every Business Challenge
Value
Demonstrates measurable ROI across internal strategy and market impact.
Value
Demonstrates measurable ROI across internal strategy and market impact.
Value
Demonstrates measurable ROI across internal strategy and market impact.
Engagement
Builds trust with stakeholder teams through actionable, cross-functional intelligence.
Engagement
Builds trust with stakeholder teams through actionable, cross-functional intelligence.
Engagement
Builds trust with stakeholder teams through actionable, cross-functional intelligence.
Reach
Extends influence across global teams, markets, and partners.
Reach
Extends influence across global teams, markets, and partners.
Reach
Extends influence across global teams, markets, and partners.
Execution
Delivers results under real-world deadlines and resource limits.
Execution
Delivers results under real-world deadlines and resource limits.
Execution
Delivers results under real-world deadlines and resource limits.
Cost Efficiency
Reliability Score
Wider Adoption
On-time delivery
Cost Efficiency
Reliability Score
Wider Adoption
On-time delivery
Cost Efficiency
Reliability Score
Wider Adoption
On-time delivery
Who We Serve
Built for Early-Stage Biotech
Who We Serve
Built for Early-Stage Biotech
10-50 employees, active Phase I/II programs, preparing for next funding round
Pre-Series B Biotech Companies
Pre-Series B Biotech Companies
VPs and directors designing trials and need competitive trial intelligence
Clinical Development Teams
Clinical Development Teams
Heads of regulatory evaluating pathway strategies and competitor precedents
Regulatory Affairs Teams
Regulatory Affairs Teams
Assessing partnership opportunities, licensing deals, or market positioning
Strategic Planning & BD Teams
Strategic Planning & BD Teams
Supporting portfolio companies with competitive intelligence for due diligence
Venture Capital Firms
Venture Capital Firms
What they all have in common
Need strategic competitive intelligence
Can't afford £50K+ enterprise contracts
Require fast turnaround (weeks, not months)
Want analyst-driven insights, not self-service platforms
Unleash the Power- LucidBio Competitive Intelligence Insight Reports
Our competitive intellegence repors offers solutions that provide a powerful way to enchance business decisionmaking and drive business growth. Uncover AI-driven risks and opportunities faster—gain clarity competitors don’t have, before they can act.
AI in Regulatory
Tracks shifting approval patterns and models how AI-driven tools influence global filing strategy.
AI in Drug Development
Maps competitor adoption of AI in trial design, forecasting, and molecule selection—revealing early advantage trends
AI in Safety Compliance
Identifies where AI tools are reshaping pharmacovigilance, audit preparedness, and risk-based monitoring across the pipeline.
LucidBio Competitive Intelligence Monthly Subscription
From quick insights to deep-dive analysis. Our CI service actionable intelligence focuses on AI trends, regulatory shifts, clinical trial strategies in oncology and competitor positioning in life sciences. No clutter. Just insight that drives results.
Learn More
Unleash the Power- LucidBio Competitive Intelligence Insight Reports
Our competitive intellegence repors offers solutions that provide a powerful way to enchance business decisionmaking and drive business growth. Uncover AI-driven risks and opportunities faster—gain clarity competitors don’t have, before they can act.
AI in Regulatory
Tracks shifting approval patterns and models how AI-driven tools influence global filing strategy.
AI in Drug Development
Maps competitor adoption of AI in trial design, forecasting, and molecule selection—revealing early advantage trends
AI in Safety Compliance
Identifies where AI tools are reshaping pharmacovigilance, audit preparedness, and risk-based monitoring across the pipeline.
LucidBio Competitive Intelligence Monthly Subscription
From quick insights to deep-dive analysis. Our CI service actionable intelligence focuses on AI trends, regulatory shifts, clinical trial strategies in oncology and competitor positioning in life sciences. No clutter. Just insight that drives results.
Learn More
Unleash the Power- LucidBio Competitive Intelligence Insight Reports
Our competitive intellegence repors offers solutions that provide a powerful way to enchance business decisionmaking and drive business growth. Uncover AI-driven risks and opportunities faster—gain clarity competitors don’t have, before they can act.
AI in Regulatory
Tracks shifting approval patterns and models how AI-driven tools influence global filing strategy.
AI in Drug Development
Maps competitor adoption of AI in trial design, forecasting, and molecule selection—revealing early advantage trends
AI in Safety Compliance
Identifies where AI tools are reshaping pharmacovigilance, audit preparedness, and risk-based monitoring across the pipeline.
LucidBio Competitive Intelligence Monthly Subscription
From quick insights to deep-dive analysis. Our CI service actionable intelligence focuses on AI trends, regulatory shifts, clinical trial strategies in oncology and competitor positioning in life sciences. No clutter. Just insight that drives results.
Learn More
Read A Snapshot of AI in Safety Compliance Competitive Intelligence Report
LucidBio AI Competitive Intelligence Reports Is An Essential Decision Making Tool
Read A Snapshot of AI in Safety Compliance Competitive Intelligence Report
LucidBio AI Competitive Intelligence Reports Is An Essential Decision Making Tool
Read A Snapshot of AI in Safety Compliance Competitive Intelligence Report
LucidBio AI Competitive Intelligence Reports Is An Essential Decision Making Tool
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Beth Johannes
Dir. Safety Compliance Lead
“Signal detection is no longer about just monitoring adverse events—AI enables proactive surveillance across global datasets, uncovering safety trends competitors may already be acting on. Competitive Intelligence reporting must integrate AI to ensure we don’t fall behind in compliance readiness or miss critical shifts in pharmacovigilance strategy.”
L. Wellington,
VP. of Oncology
“The clinical landscape changes weekly—whether it's trial delays, site selection patterns, or protocol innovations. Without AI-enhanced CI, we risk basing operational decisions on outdated assumptions. Real-time competitor insights powered by AI are now a non-negotiable asset for staying on track and ahead.
Dennis J. Lester /
CEO & Founder
"Fantastic platform! Easy to navigate, great features, and excellent support. The updates keep improving the experience. Highly satisfied!"
4.7/5 on Trustp
Dennis J. Lester /
CEO & Founder
"Fantastic platform! Easy to navigate, great features, and excellent support. The updates keep improving the experience. Highly satisfied!"
4.7/5 on Trustp
Rebit J. Lester /
Product Designer
"Amazing experience! The platform is intuitive, secure, and regularly updated. Customer support is always helpful. Definitely worth it!"
4.5/5 on Trustp
Rebit J. Lester /
Product Designer
"Amazing experience! The platform is intuitive, secure, and regularly updated. Customer support is always helpful. Definitely worth it!"
4.5/5 on Trustp
Get Started
Ready To Gain An Edge On A Volatile Life Science Landscape
AI in Safety Compliance Competitive Intelligence Report
Get Started
Ready To Gain An Edge On A Volatile Life Science Landscape
AI in Safety Compliance Competitive Intelligence Report
Get Started
Ready To Gain An Edge On A Volatile Life Science Landscape
AI in Safety Compliance Competitive Intelligence Report